Animal Antibiotics and Antimicrobials Market Size is Projected to be Around US$ 4.00 Billion By 2024
New York, August 11, 2018: Antimicrobials
and anti-infection agents shape a noteworthy share of the animalantibiotics and
antimicrobials market. At present, the worldwide antimicrobials and
anti-infection agents market is driven by the developing need to protect animal
wellbeing attributable to rising interest for animal proteins over the globe,
and developing interest in the sidekick creatures portion. Developing
domesticated animal’s populace, expanding occurrences of illness episodes and
increment in the sidekick creature possession are a portion of the elements
driving the development of this market to a specific degree. Other than the
auxiliary market drivers, there are solid geographic drivers for the
development of the animal antimicrobials and anti-infection agents showcase. The
developing markets are turning out to be progressively appealing.
REPORT SCOPE:
By Product Analysis:
Request Sample Report: https://www.marketresearchengine.com/animal-antibiotics-and-antimicrobials-market
The Animal Antibiotics and Antimicrobials Market is expected to exceed
more than US$ 4.73 Billion by 2022 at a CAGR of 4.6% in the given forecast
period.
You
Can Find Full Report @: https://www.marketresearchengine.com/animal-antibiotics-and-antimicrobials-market
The major driving factors of Animal Antibiotics and Antimicrobials
Market are as follows:
- Animal based food products demands are in raise
- Growing interest for pet protection and animal wellbeing expenditure
- Increasing occurrences of zoonotic infections
The restraining factors of Animal Antibiotics and Antimicrobials
Market are as follows:
- Lack of innovative of new antibiotic
- Growing imperviousness to antimicrobials and anti-microbials
The Animal Antibiotics and Antimicrobials Market is segmented
on the lines of its product, mode of delivery, animal type and regional. Based
on product segmentation it covers tetracyclines, penicillins, macrolides,
aminoglycosides, sulfonamides, fluoroquinolones, lincosamides, cephalosporins,
other antimicrobials and antibiotics.Based on mode of delivery segmentation it
coverspremixes, oral powders, oral solutions, injections, other modes of
delivery. Based on animal type segmentation it coversfood-producing animals,
cattle, pigs, poultry, sheep and goats, other food-producing animals, companion
animals, dogs, cats, horses, other companion animals.
This report provides:
1) An overview of the global market for Antibiotics and Antimicrobials Market and related technologies.
2) Analyses of global market trends, with data from 2013, estimates for 2014 and 2015, and projections of compound annual growth rates (CAGRs) through 2022.
3) Identifications of new market opportunities and targeted promotional plans Antibiotics and Antimicrobials Market .
4) Discussion of research and development, and the demand for new products and new applications.
5) Comprehensive company profiles of major players in the industry.
1) An overview of the global market for Antibiotics and Antimicrobials Market and related technologies.
2) Analyses of global market trends, with data from 2013, estimates for 2014 and 2015, and projections of compound annual growth rates (CAGRs) through 2022.
3) Identifications of new market opportunities and targeted promotional plans Antibiotics and Antimicrobials Market .
4) Discussion of research and development, and the demand for new products and new applications.
5) Comprehensive company profiles of major players in the industry.
REPORT SCOPE:
The scope of the report includes a detailed study of global
and regional markets onAntibiotics and Antimicrobials Market with the reasons
given for variations in the growth of the industry in certain regions.
The report covers detailed competitive outlook including the market share and company profiles of the key participants operating in the global market. Key players profiled in the report include Inc. (U.S.), Merck & Co.,Zoetis, Inc. (U.S.), Bayer AG (Germany), Eli Lilli and Company (U.S.), Virbac (France), Sanofi (France), BoehringerIngelheim GmbH (Germany), Vetoquinol S.A. (France), CevaSanteAnimale (France), and Dechra Pharmaceuticals PLC (U.K.). Company profile includes assign such as company summary, financial summary, business strategy and planning, SWOT analysis and current developments.
The report covers detailed competitive outlook including the market share and company profiles of the key participants operating in the global market. Key players profiled in the report include Inc. (U.S.), Merck & Co.,Zoetis, Inc. (U.S.), Bayer AG (Germany), Eli Lilli and Company (U.S.), Virbac (France), Sanofi (France), BoehringerIngelheim GmbH (Germany), Vetoquinol S.A. (France), CevaSanteAnimale (France), and Dechra Pharmaceuticals PLC (U.K.). Company profile includes assign such as company summary, financial summary, business strategy and planning, SWOT analysis and current developments.
By Product Analysis:
- Tetracyclines
- Penicillins
- Macrolides
- Aminoglycosides
- Sulfonamides
- Fluoroquinolones
- Lincosamides
- Cephalosporins
- Other Antimicrobials and Antibiotics
By Modes of Delivery Analysis:
- Premixes
- Oral Powders
- Oral Solutions
- Injections
- Other modes of delivery
By Animals Type Analysis:
- Food-producing Animals
- Cattle
- Pigs
- Poultry
- Sheep and Goats
- Other Food-producing Animals
- Companion Animals
- Dogs
- Cats
- Horses
- Other Companion Animals
By Regional Analysis
North
America
Europe
Asia-Pacific
Rest of the World
Europe
Asia-Pacific
Rest of the World
Request Sample Report: https://www.marketresearchengine.com/animal-antibiotics-and-antimicrobials-market
Table
of Contents
1 INTRODUCTION
2 Research
Methodology
3 Executive
Summary
4 Premium
Insights
5 Market Overview
6 Industry
Insights
7 Animal
Antimicrobials and Antibiotics Market, By Product
8 Animal
Antimicrobials and Antibiotics Market, By Mode of Delivery
9 Animal
Antimicrobials and Antibiotics Market, By Type of Animal
10 Animal
Antimicrobials and Antibiotics Market, By Region
11 Competitive
Landscape
12 Company
Profiles
12.1 Introduction
12.2 Zoetis, Inc.
12.3 Boehringer Ingelheim GmbH
12.4 Eli Lilly and Company
12.5 Merck & Co., Inc.
12.6 Bayer AG
12.7 Sanofi
12.8 Ceva Sante Animale
12.9 Virbac
12.10 Vetoquinol S.A.
12.11 Dechra Pharmaceuticals PLC
Media Contact
Contact Person: John Bay
Email: john@marketresearchengine.com
Phone: +1-855-984-1862
Country: United States
Website: https://www.marketresearchengine.com/
Comments
Post a Comment